SE9402431D0 - New tablet formulation - Google Patents
New tablet formulationInfo
- Publication number
- SE9402431D0 SE9402431D0 SE9402431A SE9402431A SE9402431D0 SE 9402431 D0 SE9402431 D0 SE 9402431D0 SE 9402431 A SE9402431 A SE 9402431A SE 9402431 A SE9402431 A SE 9402431A SE 9402431 D0 SE9402431 D0 SE 9402431D0
- Authority
- SE
- Sweden
- Prior art keywords
- tablet formulation
- formulation
- new tablet
- alkaline salt
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Priority Applications (54)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9402431A SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | New tablet formulation |
AU29938/95A AU695971B2 (en) | 1994-07-08 | 1995-06-07 | Multiple unit pharmaceutical preparation containing proton pump inhibitor |
BR9506028A BR9506028A (pt) | 1994-07-08 | 1995-06-07 | Forma farmacêutica oral de múltipla dosagem unitária em tablete processos para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem e para o tratamento das doenças inflamatórias gastrointestinais em mamiíferos e no homem e embalagem de ampola de pressão transversal |
EP04011147A EP1452172A3 (en) | 1994-07-08 | 1995-06-07 | Multiple unit pharmaceutical preparation |
CA2170644A CA2170644C (en) | 1994-07-08 | 1995-06-07 | Multiple unit pharmaceutical preparation containing proton pump inhibitor |
PL95313388A PL180598B1 (pl) | 1994-07-08 | 1995-06-07 | oraz sposób wytwarzania doustnej farmaceutycznej tabletkowanej postaci dawkowania z wieloma jednostkami PL PL PL PL PL PL PL PL |
PCT/SE1995/000678 WO1996001624A1 (en) | 1994-07-08 | 1995-06-07 | Multiple unit pharmaceutical preparation containing proton pump inhibitor |
SI9530710T SI0723437T1 (en) | 1994-07-08 | 1995-06-07 | Multiple unit pharmaceutical preparation containing proton pump inhibitor |
RU96107040/15K RU2538511C2 (ru) | 1994-07-08 | 1995-06-07 | Таблетированная многоединичная лекарственная форма, способ ее получения, способ ингибирования секреции желудочной кислоты или лечения желудочно-кишечных заболеваний у млекопитающих и человека. |
JP8504250A JPH09502741A (ja) | 1994-07-08 | 1995-06-07 | プロトンポンプ抑制剤を含有する複数単位の錠剤形の剤形 |
EE9600032A EE03292B1 (et) | 1994-07-08 | 1995-06-07 | Prootonpumba inhibiitorit sisaldav paljuosaline ravimpreparaat ja selle valmistamise protsess |
PL95313389A PL313389A1 (en) | 1994-07-08 | 1995-06-07 | Tablet-type dosage form with many units containing a proton pump inhibitor |
SK300-96A SK283841B6 (sk) | 1994-07-08 | 1995-06-07 | Multijednotková tabletovaná dávková forma, spôsob jej prípravy a jej použitie |
JP50424996A JP3878669B2 (ja) | 1994-07-08 | 1995-06-07 | プロトンポンプ抑制剤を含有する複数単位の製剤 |
PT95926055T PT723437E (pt) | 1994-07-08 | 1995-06-07 | Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes |
BR9506029A BR9506029A (pt) | 1994-07-08 | 1995-06-07 | Forma farmaêutica oral de múltipla dosagem unitária em tablete processo para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem para o tratamento de doenças inflamatórias gastrointestinais em maniferos e no homem e embalgem de ampola de pressão transversal |
NZ289949A NZ289949A (en) | 1994-07-08 | 1995-06-07 | Tablet comprising enteric coating-layered units of core material containing h+k+atpase inhibitor |
PCT/SE1995/000680 WO1996001625A1 (en) | 1994-07-08 | 1995-06-07 | Multiple unit tableted dosage form containing proton pump inhibitor |
DK95926055T DK0723437T3 (da) | 1994-07-08 | 1995-06-07 | Farmaceutisk flerenhedspræparat indeholdende protonpumpeinhibitor |
DE69533470T DE69533470T2 (de) | 1994-07-08 | 1995-06-07 | Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält |
AT95926055T ATE275396T1 (de) | 1994-07-08 | 1995-06-07 | Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält |
KR1019960701157A KR100384961B1 (ko) | 1994-07-08 | 1995-06-07 | 프로톤펌프억제제를함유하는다단위제약제제 |
US08/464,774 US5753265A (en) | 1994-07-08 | 1995-06-07 | Multiple unit pharmaceutical preparation |
CZ1996730A CZ294380B6 (cs) | 1994-07-08 | 1995-06-07 | Orální farmaceutická multijednotková tabletovaná dávková forma, balení s jejím obsahem, způsob její výroby a použití |
CNB951908197A CN1152671C (zh) | 1994-07-08 | 1995-06-07 | 含有质子泵抑制剂的多单元药物制剂 |
CN95190816A CN1134667A (zh) | 1994-07-08 | 1995-06-07 | 含有质子泵抑制剂的多单元片剂 |
RU96107040/14A RU2166935C2 (ru) | 1994-07-08 | 1995-06-07 | Таблетированная многоединичная лекарственная форма, способ ее получения, способ ингибирования секреции желудочной кислоты или лечения желудочно-кишечных заболеваний у млекопитающих и человека |
HU9600574A HUT75934A (en) | 1994-07-08 | 1995-06-07 | Pharmaceutical multiple unit tableted dosage form comprising individually enteric coating layered units containing proton pump inhibitor as active ingredient |
EP95926055A EP0723437B1 (en) | 1994-07-08 | 1995-06-07 | Multiple unit pharmaceutical preparation containing proton pump inhibitor |
CA002170995A CA2170995A1 (en) | 1994-07-08 | 1995-06-07 | Multiple unit tableted dosage form containing proton pump inhibitor |
HU9600572A HU9600572D0 (en) | 1994-07-08 | 1995-06-07 | Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form |
UA96030836A UA47390C2 (uk) | 1994-07-08 | 1995-06-07 | Таблетована багатоодинична лікарська форма, спосіб приготування вказаної форми та спосіб інгібування секреції шлункової кислоти у ссавців та людини |
ES95926055T ES2227556T3 (es) | 1994-07-08 | 1995-06-07 | Preparacion farmaceutica de unidades multiples que contiene un inhibidor de las bombas de protones. |
TW084106116A TW421599B (en) | 1994-07-08 | 1995-06-15 | Multiple unit pharmaceutical preparation |
ZA955546A ZA955546B (en) | 1994-07-08 | 1995-07-04 | Multiple unit tableted dosage form II |
IL11444795A IL114447A (en) | 1994-07-08 | 1995-07-04 | Multi-unit tablets, containing an unstable H + K + - ATPase inhibitor for its acid or single enantiomer or its alkaline salt, pharmaceutical preparations containing it, and a process for its preparation |
ZA955547A ZA955547B (en) | 1994-07-08 | 1995-07-04 | Multiple unit pharmaceutical preparation |
IL11444995A IL114449A0 (en) | 1994-07-08 | 1995-07-04 | Multiple unit tableted dosage form |
MA23947A MA23608A1 (fr) | 1994-07-08 | 1995-07-06 | Forme de dosage ii d'unite multiple en comprime |
TR95/00825A TR199500825A2 (tr) | 1994-07-08 | 1995-07-06 | Cok üniteli farmasötik müstahzar. |
TR95/00826A TR199500826A2 (tr) | 1994-07-08 | 1995-07-06 | Multipl ünite tablet doz formu 2. |
EP95926056A EP0724434A1 (en) | 1994-07-08 | 1995-07-07 | Multiple unit tableted dosage form containing proton pump inhibitor |
TNTNSN95076A TNSN95076A1 (fr) | 1994-07-08 | 1995-07-07 | Forme de dosage ii d'unite multiple en comprime |
MYPI95001921A MY114388A (en) | 1994-07-08 | 1995-07-08 | Multiple unit pharmaceutical preparation |
SA95160092A SA95160092B1 (ar) | 1994-07-08 | 1995-07-09 | مستحضر صيدلي متعدد الوحدات |
IS4329A IS4329A (is) | 1994-07-08 | 1996-03-04 | Fjöleiningaskammtar í töfluformi sem innihalda prótónupumpublokkara |
IS4326A IS4326A (is) | 1994-07-08 | 1996-03-04 | Ný forðakyrni og lyfjablanda sem inniheldur þau |
IS4328A IS4328A (is) | 1994-07-08 | 1996-03-04 | Fjöleininga lyfjablanda sem inniheldur prótónupumpublokkara |
MXPA/A/1996/000856A MXPA96000856A (en) | 1994-07-08 | 1996-03-05 | Pharmaceutical preparation of multiple units, which contain an inhibitor of the proto pump |
FI961058A FI122016B (sv) | 1994-07-08 | 1996-03-07 | Farmaceutiskt flerenhetspreparat innehållande protonpumpinhibitor |
NO19960948A NO316863B1 (no) | 1994-07-08 | 1996-03-07 | Oral farmasoytisk, tablettert multippel enhetsdoseringsfom, fremgangsmate for dens fremstilling, anvendelse derav, og blaerepakning |
FI961059A FI961059A0 (sv) | 1994-07-08 | 1996-03-07 | Tabletterad flerenhetsdoseringsform innehållande protonpumpinhibitor |
NO960949A NO960949D0 (no) | 1994-07-08 | 1996-03-07 | Tablettert flerdoseenhetsform inneholdende protonpumpeinhibitor |
HK98109226A HK1008298A1 (en) | 1994-07-08 | 1998-07-17 | Multiple unit pharmaceutical preparation containing proton pump inhibitor. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9402431A SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | New tablet formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9402431D0 true SE9402431D0 (sv) | 1994-07-08 |
Family
ID=20394685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9402431A SE9402431D0 (sv) | 1994-07-08 | 1994-07-08 | New tablet formulation |
Country Status (36)
Country | Link |
---|---|
US (1) | US5753265A (sv) |
EP (3) | EP1452172A3 (sv) |
JP (2) | JPH09502741A (sv) |
KR (1) | KR100384961B1 (sv) |
CN (2) | CN1152671C (sv) |
AT (1) | ATE275396T1 (sv) |
AU (1) | AU695971B2 (sv) |
BR (2) | BR9506028A (sv) |
CA (2) | CA2170644C (sv) |
CZ (1) | CZ294380B6 (sv) |
DE (1) | DE69533470T2 (sv) |
DK (1) | DK0723437T3 (sv) |
EE (1) | EE03292B1 (sv) |
ES (1) | ES2227556T3 (sv) |
FI (2) | FI961059A0 (sv) |
HK (1) | HK1008298A1 (sv) |
HU (2) | HUT75934A (sv) |
IL (2) | IL114447A (sv) |
IS (3) | IS4329A (sv) |
MA (1) | MA23608A1 (sv) |
MY (1) | MY114388A (sv) |
NO (2) | NO960949D0 (sv) |
NZ (1) | NZ289949A (sv) |
PL (2) | PL313389A1 (sv) |
PT (1) | PT723437E (sv) |
RU (2) | RU2538511C2 (sv) |
SA (1) | SA95160092B1 (sv) |
SE (1) | SE9402431D0 (sv) |
SI (1) | SI0723437T1 (sv) |
SK (1) | SK283841B6 (sv) |
TN (1) | TNSN95076A1 (sv) |
TR (2) | TR199500826A2 (sv) |
TW (1) | TW421599B (sv) |
UA (1) | UA47390C2 (sv) |
WO (2) | WO1996001624A1 (sv) |
ZA (2) | ZA955546B (sv) |
Families Citing this family (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
JP3350054B2 (ja) * | 1994-07-08 | 2002-11-25 | アストラゼネカ・アクチエボラーグ | 複数単位の錠剤化された剤形▲i▼ |
ES2094694B1 (es) * | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
NZ318501A (en) * | 1995-09-21 | 1999-06-29 | Pharma Pass Llc | Novel composition containing an acid-labile omeprazole and process for its preparation |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
SE9602442D0 (sv) * | 1996-06-20 | 1996-06-20 | Astra Ab | Administration of pharmaceuticals |
US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
CN1268137A (zh) | 1997-07-03 | 2000-09-27 | 杜邦药品公司 | 治疗神经失调的咪唑并嘧啶和咪唑并吡啶 |
ES2137862B1 (es) * | 1997-07-31 | 2000-09-16 | Intexim S A | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
US20050244497A1 (en) * | 1997-11-05 | 2005-11-03 | Wockhardt Limited | Delayed delivery system for acid-sensitive drugs |
US6174548B1 (en) * | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6602522B1 (en) * | 1997-11-14 | 2003-08-05 | Andrx Pharmaceuticals L.L.C. | Pharmaceutical formulation for acid-labile compounds |
PL195266B1 (pl) * | 1997-12-08 | 2007-08-31 | Altana Pharma Ag | Jednostka związku aktywnego nietrwałego w środowisku kwaśnym, sposób jej otrzymywania, czopki zawierające aktywny związek nietrwały w środowisku kwaśnym oraz sposób ich otrzymywania |
SE9704870D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
FR2774288B1 (fr) | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
DK1736144T3 (en) | 1998-05-18 | 2015-12-07 | Takeda Pharmaceutical | Orally disintegrating tablets. |
US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
ATE481090T1 (de) | 1998-07-28 | 2010-10-15 | Takeda Pharmaceutical | Leicht zerfallende feste zubereitung |
JP4988088B2 (ja) | 1998-08-12 | 2012-08-01 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | ピリジン−2−イルメチルスルフィニル−1h−ベンズイミダゾール、もしくはピリジン−2−イルメチルスルフィニル−1h−ベンズイミダゾールの骨格を有する化合物、またはその薬学的に許容される塩の経口投与形組成物を固定的に組み合わせた組成物 |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
WO2000026185A2 (en) * | 1998-10-30 | 2000-05-11 | The Curators Of The University Of Missouri | Omeprazole solution and method of using same |
NZ511169A (en) * | 1998-11-18 | 2003-06-30 | Astrazeneca Ab | Process for making substituted sulphinyl heterocycles containing an imidazole moiety |
US6174902B1 (en) | 1999-04-28 | 2001-01-16 | Sepracor Inc. | R-rabeprazole compositions and methods |
FR2793688B1 (fr) * | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
CA2376202C (en) | 1999-06-07 | 2008-11-18 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel preparation and administration form comprising an acid-labile active compound |
IL130602A0 (en) * | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
ES2168043B1 (es) | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
WO2002004411A1 (en) | 2000-07-07 | 2002-01-17 | The Administrators Of The Tulane Educational Fund | Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor |
US20020064555A1 (en) * | 2000-09-29 | 2002-05-30 | Dan Cullen | Proton pump inhibitor formulation |
WO2002045694A1 (en) | 2000-12-07 | 2002-06-13 | Altana Pharma Ag | Rapidly disintegrating tablet comprising an acid-labile active ingredient |
US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
JP5138856B2 (ja) * | 2001-06-20 | 2013-02-06 | 武田薬品工業株式会社 | 錠剤の製造方法 |
CA2451135C (en) | 2001-06-20 | 2012-10-09 | Takeda Chemical Industries, Ltd. | Method of manufacturing tablet |
CN100408029C (zh) * | 2001-09-28 | 2008-08-06 | 麦克内尔-Ppc股份有限公司 | 有镶嵌部分的组合剂型 |
JP4331930B2 (ja) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | 酸に不安定な薬物の高含量顆粒 |
JP2006282677A (ja) * | 2001-10-17 | 2006-10-19 | Takeda Chem Ind Ltd | 酸に不安定な薬物の高含量顆粒 |
EP2258351B1 (en) | 2001-10-17 | 2013-06-19 | Takeda Pharmaceutical Company Limited | Granules containing lansoprazole in large amount |
ES2198195B1 (es) * | 2001-12-18 | 2004-10-01 | Laboratorios Del Dr. Esteve, S.A. | Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido. |
CA2472103A1 (en) * | 2002-01-25 | 2003-08-07 | Santarus, Inc. | Transmucosal delivery of proton pump inhibitors |
US7125563B2 (en) * | 2002-04-12 | 2006-10-24 | Dava Pharmaceuticals, Inc. | Sustained release pharmaceutical preparations and methods for producing the same |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
US6902746B2 (en) * | 2002-07-03 | 2005-06-07 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same |
US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
TW200410955A (en) | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
FR2845289B1 (fr) * | 2002-10-04 | 2004-12-03 | Ethypharm Sa | Spheroides, procede de preparation et compositions pharmaceutiques. |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
FR2845917B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US20040166162A1 (en) * | 2003-01-24 | 2004-08-26 | Robert Niecestro | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
EP1594479A1 (en) * | 2003-01-31 | 2005-11-16 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions and processes for their preparation |
CA2517005A1 (en) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US7507746B2 (en) * | 2003-02-24 | 2009-03-24 | Mitsubishi Pharma Corporation | Enantiomer of tenatoprazole and the use thereof in therapy |
US20040213847A1 (en) * | 2003-04-23 | 2004-10-28 | Matharu Amol Singh | Delayed release pharmaceutical compositions containing proton pump inhibitors |
CL2004000983A1 (es) * | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
US8802139B2 (en) * | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
DE602004025113D1 (de) * | 2003-07-11 | 2010-03-04 | Astrazeneca Ab | Feste zusammensetzung mit einem protonenpumpenhemmer |
AR045062A1 (es) * | 2003-07-18 | 2005-10-12 | Santarus Inc | Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050031700A1 (en) * | 2003-07-18 | 2005-02-10 | Sanatarus, Inc. | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
AR045068A1 (es) * | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
JP2005306778A (ja) * | 2004-04-21 | 2005-11-04 | Basf Ag | 徐放性製剤及びその製造方法 |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
WO2005123042A1 (en) * | 2004-06-10 | 2005-12-29 | Glatt Air Techniques, Inc. | Controlled release pharmaceutical formulation |
JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | Ppi多回剤形 |
FR2871800B1 (fr) * | 2004-06-17 | 2006-08-25 | Sidem Pharma Sa Sa | Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique |
US20050281876A1 (en) * | 2004-06-18 | 2005-12-22 | Shun-Por Li | Solid dosage form for acid-labile active ingredient |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US20060134210A1 (en) * | 2004-12-22 | 2006-06-22 | Astrazeneca Ab | Solid dosage form comprising proton pump inhibitor and suspension made thereof |
US8673352B2 (en) * | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
EP1813275A1 (en) * | 2005-12-20 | 2007-08-01 | Teva Pharmaceutical Industries Ltd | Lansoprazole orally disintegrating tablets |
JP2009524592A (ja) * | 2005-12-20 | 2009-07-02 | テバ ファーマシューティカル インダストリーズ リミティド | ランソプラゾール経口崩壊錠剤 |
US20070141151A1 (en) * | 2005-12-20 | 2007-06-21 | Silver David I | Lansoprazole orally disintegrating tablets |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
SG184754A1 (en) * | 2005-12-28 | 2012-10-30 | Takeda Pharmaceutical | Controlled release solid preparation |
US20070154542A1 (en) * | 2005-12-30 | 2007-07-05 | Cogentus Pharmaceuticals, Inc. | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
CA2648280C (en) * | 2006-04-03 | 2014-03-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
KR101784001B1 (ko) * | 2006-04-04 | 2017-10-23 | 케이지 액퀴지션 엘엘씨 | 항혈소판제와 산 억제제를 포함하는 경구 투여용 약학 조성물 |
US9532945B2 (en) * | 2006-04-04 | 2017-01-03 | Kg Acquisition Llc | Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor |
EP2012756A4 (en) * | 2006-04-20 | 2013-01-23 | Inventia Healthcare Private Ltd | MULTI-UNIT COMPOSITIONS |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
JP2009538901A (ja) * | 2006-06-01 | 2009-11-12 | デクセル ファーマ テクノロジーズ エルティーディー. | 複式ユニット製薬的製剤 |
CN101500553B (zh) * | 2006-07-25 | 2012-04-18 | 维克塔有限公司 | 联合使用小分子二羧酸的衍生物与ppi用于抑制胃酸分泌的组合物和方法 |
RU2009106681A (ru) * | 2006-07-28 | 2010-09-10 | Др.Редди`С Лабораторис Лтд. (In) | Гранулированные фармацевтические композиции |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
TR200605624A2 (tr) * | 2006-10-10 | 2008-05-21 | Nobel İlaç Sanayi̇ Ve Ti̇caret Aş. | Farmasötik dozaj şekli |
WO2008057802A2 (en) | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
US8352042B2 (en) * | 2006-11-28 | 2013-01-08 | The Alfred E. Mann Foundation For Scientific Research | Remote controls and ambulatory medical systems including the same |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
DE102007009242A1 (de) | 2007-02-22 | 2008-09-18 | Evonik Röhm Gmbh | Pellets mit magensaftresistenter Wirkstoff-Matix |
EP2044932A1 (en) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Mechanical protective layer for solid dosage forms |
US8173158B2 (en) | 2007-10-12 | 2012-05-08 | Takeda Pharmaceuticals U.S.A., Inc. | Methods of treating gastrointestinal disorders independent of the intake of food |
WO2009105568A1 (en) | 2008-02-20 | 2009-08-27 | The Curators Of The University Of Missouri | Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same |
WO2009113703A2 (en) | 2008-03-11 | 2009-09-17 | Takeda Pharmaceutical Company Limited | Orally-disintegrating solid preparation |
TWI519322B (zh) * | 2008-04-15 | 2016-02-01 | 愛戴爾製藥股份有限公司 | 包含弱鹼性藥物及控制釋放劑型之組合物 |
US20090280173A1 (en) * | 2008-05-09 | 2009-11-12 | Ishwar Chauhan | Multilayer Omeprazole Tablets |
US20090280175A1 (en) * | 2008-05-09 | 2009-11-12 | Ishwar Chauhan | Multilayer Proton Pump Inhibitor Tablets |
EP2345408A3 (en) | 2010-01-08 | 2012-02-29 | Dr. Reddy's Laboratories Ltd. | Acid labile drug formulations |
WO2011103920A2 (en) | 2010-02-25 | 2011-09-01 | Evonik Röhm Gmbh | Pharmaceutical or neutraceutical formulation |
US20130202688A1 (en) | 2010-05-04 | 2013-08-08 | Sunilendu Bhushan Roy | Delayed release oral disintegrating pharmaceutical compositions of lansoprazole |
MX2013000827A (es) | 2010-07-22 | 2013-06-28 | Lupin Ltd | Composicion de tableta de unidad multiple. |
IT1401284B1 (it) * | 2010-08-06 | 2013-07-18 | Valpharma S P A | Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system). |
EP2468263A1 (en) * | 2010-12-23 | 2012-06-27 | Laboratorios Del. Dr. Esteve, S.A. | Compressed solid dosage forms |
CN102805735A (zh) * | 2011-06-21 | 2012-12-05 | 寿光富康制药有限公司 | 一种埃索美拉唑肠溶微丸片及其制备方法 |
WO2013064535A1 (en) * | 2011-11-02 | 2013-05-10 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical composition of omeprazole |
GB201417828D0 (en) | 2014-10-08 | 2014-11-19 | Cereno Scient Ab | New methods and compositions |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
CZ2017315A3 (cs) | 2017-06-02 | 2018-12-12 | Zentiva, K.S. | Dávkovací jednotka s PPI (inhibitory protonové pumpy) |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1545612A (fr) * | 1967-06-15 | 1968-11-15 | Dausse Lab | Procédé de fabrication de comprimés |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
AU4640985A (en) * | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
GB8630080D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
SE8804629D0 (sv) * | 1988-12-22 | 1988-12-22 | Ab Haessle | New therapeutically active compounds |
WO1991019712A1 (en) * | 1990-06-20 | 1991-12-26 | Aktiebolaget Astra | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
YU48263B (sh) * | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
DE69127275T2 (de) * | 1991-06-21 | 1998-03-12 | Ilsan Ilac Ve Hammaddeleri San | Neues galenisches Verfahren für Omeprazol enthaltende Pellets |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
ATE219931T1 (de) * | 1993-10-12 | 2002-07-15 | Mitsubishi Pharma Corp | Darmlösliche grannulatkörner enthaltende tablette |
JP3350054B2 (ja) * | 1994-07-08 | 2002-11-25 | アストラゼネカ・アクチエボラーグ | 複数単位の錠剤化された剤形▲i▼ |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
-
1994
- 1994-07-08 SE SE9402431A patent/SE9402431D0/sv unknown
-
1995
- 1995-06-07 CN CNB951908197A patent/CN1152671C/zh not_active Expired - Lifetime
- 1995-06-07 RU RU96107040/15K patent/RU2538511C2/ru not_active IP Right Cessation
- 1995-06-07 BR BR9506028A patent/BR9506028A/pt active Search and Examination
- 1995-06-07 SI SI9530710T patent/SI0723437T1/xx unknown
- 1995-06-07 WO PCT/SE1995/000678 patent/WO1996001624A1/en active IP Right Grant
- 1995-06-07 WO PCT/SE1995/000680 patent/WO1996001625A1/en not_active Application Discontinuation
- 1995-06-07 PT PT95926055T patent/PT723437E/pt unknown
- 1995-06-07 EP EP04011147A patent/EP1452172A3/en not_active Withdrawn
- 1995-06-07 BR BR9506029A patent/BR9506029A/pt not_active Application Discontinuation
- 1995-06-07 HU HU9600574A patent/HUT75934A/hu not_active Application Discontinuation
- 1995-06-07 NZ NZ289949A patent/NZ289949A/en not_active IP Right Cessation
- 1995-06-07 EP EP95926055A patent/EP0723437B1/en not_active Revoked
- 1995-06-07 JP JP8504250A patent/JPH09502741A/ja active Pending
- 1995-06-07 PL PL95313389A patent/PL313389A1/xx unknown
- 1995-06-07 CZ CZ1996730A patent/CZ294380B6/cs not_active IP Right Cessation
- 1995-06-07 US US08/464,774 patent/US5753265A/en not_active Expired - Lifetime
- 1995-06-07 JP JP50424996A patent/JP3878669B2/ja not_active Expired - Lifetime
- 1995-06-07 ES ES95926055T patent/ES2227556T3/es not_active Expired - Lifetime
- 1995-06-07 KR KR1019960701157A patent/KR100384961B1/ko not_active IP Right Cessation
- 1995-06-07 PL PL95313388A patent/PL180598B1/pl unknown
- 1995-06-07 HU HU9600572A patent/HU9600572D0/hu unknown
- 1995-06-07 UA UA96030836A patent/UA47390C2/uk unknown
- 1995-06-07 AT AT95926055T patent/ATE275396T1/de active
- 1995-06-07 CN CN95190816A patent/CN1134667A/zh active Pending
- 1995-06-07 CA CA2170644A patent/CA2170644C/en not_active Expired - Lifetime
- 1995-06-07 DK DK95926055T patent/DK0723437T3/da active
- 1995-06-07 DE DE69533470T patent/DE69533470T2/de not_active Expired - Lifetime
- 1995-06-07 CA CA002170995A patent/CA2170995A1/en not_active Abandoned
- 1995-06-07 RU RU96107040/14A patent/RU2166935C2/ru not_active IP Right Cessation
- 1995-06-07 EE EE9600032A patent/EE03292B1/xx unknown
- 1995-06-07 AU AU29938/95A patent/AU695971B2/en not_active Expired
- 1995-06-07 SK SK300-96A patent/SK283841B6/sk not_active IP Right Cessation
- 1995-06-15 TW TW084106116A patent/TW421599B/zh not_active IP Right Cessation
- 1995-07-04 ZA ZA955546A patent/ZA955546B/xx unknown
- 1995-07-04 IL IL11444795A patent/IL114447A/en not_active IP Right Cessation
- 1995-07-04 ZA ZA955547A patent/ZA955547B/xx unknown
- 1995-07-04 IL IL11444995A patent/IL114449A0/xx unknown
- 1995-07-06 TR TR95/00826A patent/TR199500826A2/xx unknown
- 1995-07-06 TR TR95/00825A patent/TR199500825A2/xx unknown
- 1995-07-06 MA MA23947A patent/MA23608A1/fr unknown
- 1995-07-07 EP EP95926056A patent/EP0724434A1/en not_active Withdrawn
- 1995-07-07 TN TNTNSN95076A patent/TNSN95076A1/fr unknown
- 1995-07-08 MY MYPI95001921A patent/MY114388A/en unknown
- 1995-07-09 SA SA95160092A patent/SA95160092B1/ar unknown
-
1996
- 1996-03-04 IS IS4329A patent/IS4329A/is unknown
- 1996-03-04 IS IS4326A patent/IS4326A/is unknown
- 1996-03-04 IS IS4328A patent/IS4328A/is unknown
- 1996-03-07 NO NO960949A patent/NO960949D0/no unknown
- 1996-03-07 NO NO19960948A patent/NO316863B1/no not_active IP Right Cessation
- 1996-03-07 FI FI961059A patent/FI961059A0/sv unknown
- 1996-03-07 FI FI961058A patent/FI122016B/sv not_active IP Right Cessation
-
1998
- 1998-07-17 HK HK98109226A patent/HK1008298A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9402431D0 (sv) | New tablet formulation | |
MY112915A (en) | Multiple unit tableted dosage form 1 | |
CA2214027A1 (en) | Multiple unit effervescent dosage forms comprising proton pump inhibitor | |
SE9500422D0 (sv) | New oral pharmaceutical dosage forms | |
MA23170A1 (fr) | Procede de preparation d'un nouveau compose . | |
DE69511089T2 (de) | Metalloproteinase-inhibitoren | |
DK0710108T3 (da) | Flydende, farmaceutisk præparat til oral anvendelse indeholdende 2-(4-isobutylphenyl)-propionsyre | |
JO1881B1 (en) | Formula II for multi unit disc calibration | |
JO1880B1 (en) | Format 1 for multi-unit calibration discs |